Trial Details
Not RecruitingBasic Information
| Clinical ID | c2720 |
|---|---|
| Identifier | NL-OMON23533 |
| Trial Title | Deep profiling of lipid changes in patients with active ulcerative colitis treated with either tofacitinib or infliximab |
| Trial URL | Visit Original Page |
Study Information
| Study Results | No results available |
|---|---|
| Conditions | Ulcerative colitis__Lipids__Tofacitinib__Infliximab |
| Interventions | Randomization in a 1:1 to either: - tofacitinib arm: induction therapy 10mg oral tablets twice daily during 8 weeks and maintenance therapy 5mg tablets twice daily until week 52 - infliximab arm: induction therapy with infliximab infusions 5mg/kg on week 0, 2 and 6 and maintenance therapy of infliximab infusions 5/mg/kg every 8 weeks Additional interventions: - vena punction for serum sample analyses - home test for stool sampling - questionnaires (- preferably, endoscopy) |
Participant Information
| Sponsor | Erasmus Medical Center |
|---|---|
| City | - |
| Country/Region | - |
Enrollment Criteria
| Sex Requirement | NOT SPECIFIED |
|---|---|
| Age Requirement | - |
Study Design
| Study Type | Observational non invasive |
|---|---|
| Phase | Not Available |
Time Information
| Start Date | 2025-04-24 |
|---|---|
| Primary Completion Date | - |
| Completion Date | - |